212 0

Full metadata record

DC FieldValueLanguage
dc.contributor.author성윤경-
dc.date.accessioned2018-03-26T05:25:10Z-
dc.date.available2018-03-26T05:25:10Z-
dc.date.issued2013-07-
dc.identifier.citation대한류마티스학회지(The Journal of the Korean Rheumatism Association), 2013, 20(3), P.156-165, 10P.en_US
dc.identifier.issn2093-940X-
dc.identifier.urihttps://synapse.koreamed.org/DOIx.php?id=10.4078/jrd.2013.20.3.156-
dc.identifier.urihttp://hdl.handle.net/20.500.11754/52358-
dc.description.abstractObjectives. To investigate the perception of and treatment pattern with regard to the four important issues in the management of lupus nephritis (LN), and to identify which parts of the LN treatment are difficult for physicians to carry out in clinical practice. Methods. Four steps were carried out: pre-survey, LN symposium, post-survey, and meeting after the symposium.The two surveys were conducted with the same contents regarding renal biopsy, induction and maintenance treatment for class III and IV LN, and treatment for class V LN. The results of the first survey and the changes in opinion reflected in the second survey were comparatively analyzed. Results. In the first survey, most of the respondent physicians replied that they would immediately conduct biopsy in the case of significant proteinuria. For the induction treatment of class III and IV LN, most of the respondent physicians selected high-dose cyclophosphamide. Mycophenolate mofetil and steroid combination therapy were selected for the maintenance treatment, and tacrolimus for the treatment of class V LN. There was a controversy in the drug selection, however, especially on the maintenance treatment of class III and IV LN and on the treatment of non-responsive class V LN. Conclusion. Some discrepancies were found in the treatment of LN in the real world. Although no recommendation was made for Korean LN patients in this study, the study results will help physicians select the most reasonable treatment for Korean LN patients based on experts` experiences and objective evidence.en_US
dc.description.sponsorshipThis study was supported by a grant from the Korean Lupus Network (A080588-15) and from Astellas Pharm Korea, Inc.en_US
dc.language.isoenen_US
dc.publisher대한류마티스학회en_US
dc.subjectLupus nephritisen_US
dc.subjectTreatmenten_US
dc.subjectGuidelineen_US
dc.titleDiagnosis and Treatment of Lupus Nephritis: Survey Results on Four Important Issuesen_US
dc.typeArticleen_US
dc.relation.no3-
dc.relation.volume20-
dc.identifier.doi10.4078/jrd.2013.20.3.156-
dc.relation.page156-165-
dc.relation.journal대한류마티스학회지-
dc.contributor.googleauthorJoo, Young Bin-
dc.contributor.googleauthorSung, Yoon Kyoung-
dc.contributor.googleauthorPark, Yong Beom-
dc.contributor.googleauthorSuh, Chang Hee-
dc.contributor.googleauthorShim, Seung Cheol-
dc.contributor.googleauthorLee, Young Ho-
dc.contributor.googleauthorLee, Ji Soo-
dc.contributor.googleauthorLee, Hye Soon-
dc.contributor.googleauthorCha, Hoon Suk-
dc.contributor.googleauthorBae, Sang Cheol-
dc.relation.code2012214945-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.pidsungyk-
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > ETC
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE